For example, inhibition of IFNγ-induced STAT1 signaling protects against atherosclerosis development [33] and IFNγ is associated with the development of AT in obese patients [34] and diminishes insulin signaling in human adipocytes [35]. This evidence concerns the gene STAT1 and atherosclerosis.